Clinical Trial Update: E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing E7389 to capecitabine in metastatic breast cancer previously treated with anthracyclines and taxanes has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• E7389 (eribulin)

Snippet

Sponsor: Eisai Inc. | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-09-30